AdaptHealth (AHCO) | Stock Overview & Key Data
AdaptHealth Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $41.58 on February 1, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| AdaptHealth AHCO | 1.13B Small-cap | 1.38% | 8.05% | 5.89% | -5.64% | -1.75% | -12.82% | -54.07% | -51.26% |
| Abbott Laboratories ABT | 231.85B Mega-cap | -2.13% | -0.03% | 7.59% | 16.73% | 17.56% | 28.29% | 22.86% | 34.71% |
| Boston Scientific BSX | 149.87B Large-cap | -2.26% | 2.37% | 12.99% | 6.73% | 14.58% | 33.65% | 176.51% | 175.34% |
| UFP Technologies UFPT | 1.88B Small-cap | -1.27% | 1.21% | 22.38% | -0.35% | -2.10% | -14.95% | 211.86% | 462.69% |
| Alphatec Holdings ATEC | 1.59B Small-cap | 6.13% | -2.68% | 23.01% | 20.08% | 28.04% | -2.84% | 63.87% | 113.48% |
| Novocure NVCR | 1.85B Small-cap | -5.11% | -0.06% | 1.69% | -41.78% | -43.68% | 5.54% | -76.20% | -70.67% |
Ownership & Short Interest
AdaptHealth Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in AdaptHealth would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
In the last 52 weeks, AdaptHealth reached a high of $11.90 (on July 25, 2024) and a low of $7.11 (on April 21, 2025).
Curious about AdaptHealth's size and valuation? Its market capitalization stands at 1.13B. When it comes to valuation, the P/E ratio (trailing twelve months) is 14.47, and the forward P/E (looking ahead) is 9.87.
As for dividends, AdaptHealth isn't currently offering a significant yield, or that specific data isn't available right now.
When looking at AdaptHealth, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT231.85B Healthcare Medical Devices 28.29% 22.86% Boston Scientific
BSX149.87B Healthcare Medical Devices 33.65% 176.51% UFP Technologies
UFPT1.88B Healthcare Medical Devices -14.95% 211.86% Alphatec Holdings
ATEC1.59B Healthcare Medical Devices -2.84% 63.87% Novocure
NVCR1.85B Healthcare Medical Devices 5.54% -76.20% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
To get a sense of AdaptHealth's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.90%, the Debt to Equity ratio from the most recent quarter is 133.64, and its Gross Profit Margin stands at -13.26%.
Looking at AdaptHealth's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.80%, and quarterly earnings saw a YoY growth of -2.29%.
Wondering who owns AdaptHealth stock? Company insiders (like executives and directors) hold about 7.99% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 102.26%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.